Sanjay Subramanian - Mar 31, 2025 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO & Head of BD
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 31, 2025
Transactions value $
$1,917
Form type
4
Date filed
4/2/2025, 04:27 PM
Previous filing
Mar 17, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $1.92K +2.49K +8.19% $0.77 32.9K Mar 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2024 through March 31, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on March 31, 2025, the last trading day of the purchase period.